Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised the shareholders of The Research Partnership Limited on the deal. The Research Partnership Limited (Research Partnership) on its acquisition by Ashfield Huntsworth for...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Mura Technology on its multi-million dollar partnership with Dow. The partnership will support the rapid scaling of Mura’s new HydroPRS™ process to...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised the management team of Lucid Group, a leading global healthcare communications company, LDC and other shareholders on its partnership with new investor Intermediate...
You must be a Standard 1 Year member to access this content.
